These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Determination of Clinical Characteristics of Kim YG; Lee HY; Kwak N; Park JH; Kim TS; Kim MJ; Lee JS; Park SS; Yim JJ; Seong MW Ann Lab Med; 2021 Sep; 41(5):463-468. PubMed ID: 33824234 [TBL] [Abstract][Full Text] [Related]
23. Spatial Heterogeneity of Nontuberculous Mycobacterial Pulmonary Disease in Shanghai: Insights from a Ten-Year Population-Based Study. Zhang Y; Sun R; Yu C; Li J; Lin H; Huang J; Wang Y; Shen X; Jiang Y; Yang C; Xu B Int J Infect Dis; 2024 Jun; 143():107001. PubMed ID: 38461931 [TBL] [Abstract][Full Text] [Related]
24. False-positive Gen-Probe direct Mycobacterium tuberculosis amplification test results for patients with pulmonary M. kansasii and M. avium infections. Jorgensen JH; Salinas JR; Paxson R; Magnon K; Patterson JE; Patterson TF J Clin Microbiol; 1999 Jan; 37(1):175-8. PubMed ID: 9854086 [TBL] [Abstract][Full Text] [Related]
25. Uveitis with occult choroiditis due to Mycobacterium kansasii: limitations of interferon-gamma release assay (IGRA) tests (case report and mini-review on ocular non-tuberculous mycobacteria and IGRA cross-reactivity). Kuznetcova TI; Sauty A; Herbort CP Int Ophthalmol; 2012 Oct; 32(5):499-506. PubMed ID: 22661050 [TBL] [Abstract][Full Text] [Related]
26. Clinical and radiological features of Mycobacterium kansasii and other NTM infections. Matveychuk A; Fuks L; Priess R; Hahim I; Shitrit D Respir Med; 2012 Oct; 106(10):1472-7. PubMed ID: 22850110 [TBL] [Abstract][Full Text] [Related]
28. Mycobacterium kansasii, species or complex? Biomolecular and epidemiological insights. Tortoli E Kekkaku; 2003 Nov; 78(11):705-9. PubMed ID: 14672048 [TBL] [Abstract][Full Text] [Related]
29. A Murine Model of Mussi VO; Simão TLBV; Almeida FM; Machado E; de Carvalho LD; Calixto SD; Sales GAM; Carvalho ECQ; Vasconcellos SEG; Catanho M; Suffys PN; Lasunskaia EB Front Microbiol; 2021; 12():718477. PubMed ID: 34504483 [TBL] [Abstract][Full Text] [Related]
30. Heterologous Production of 1-Tuberculosinyladenosine in Mycobacterium kansasii Models Pathoevolution towards the Transcellular Lifestyle of Mycobacterium tuberculosis. Ghanem M; Dubé JY; Wang J; McIntosh F; Houle D; Domenech P; Reed MB; Raman S; Buter J; Minnaard AJ; Moody DB; Behr MA mBio; 2020 Oct; 11(5):. PubMed ID: 33082253 [No Abstract] [Full Text] [Related]
31. ESAT-6 and CFP-10 in clinical versus environmental isolates of Mycobacterium kansasii. Arend SM; de Haas P; Leyten E; Rosenkrands I; Rigouts L; Andersen P; Mijs W; van Dissel JT; van Soolingen D J Infect Dis; 2005 Apr; 191(8):1301-10. PubMed ID: 15776377 [TBL] [Abstract][Full Text] [Related]
32. Pulmonary Padmapriyadarsini C; Nair D; Gomathi NS; Velayudham B Indian J Med Microbiol; 2016; 34(4):516-519. PubMed ID: 27934834 [TBL] [Abstract][Full Text] [Related]
33. Mycobacterium kansasii pulmonary diseases in Korea. Yim JJ; Park YK; Lew WJ; Bai GH; Han SK; Shim YS J Korean Med Sci; 2005 Dec; 20(6):957-60. PubMed ID: 16361804 [TBL] [Abstract][Full Text] [Related]
34. [Distribution and drug resistance of nontuberculous Zhang J; Su JR; Ding BC; Liu JW; Yi JL; Yang XY; Wang NH; Wang SM Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):210-214. PubMed ID: 28297817 [No Abstract] [Full Text] [Related]
35. Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology. Corbett EL; Hay M; Churchyard GJ; Herselman P; Clayton T; Williams BG; Hayes R; Mulder D; De Cock KM Int J Tuberc Lung Dis; 1999 Jun; 3(6):501-7. PubMed ID: 10383063 [TBL] [Abstract][Full Text] [Related]
36. Drug susceptibility profile of Mycobacterium kansasii clinical isolates from Brazil. de Carvalho LD; de Queiroz Mello FC; Redner P; Campos CED; de Souza Caldas PC; da Silva Lourenço MC; Ramos JP J Glob Antimicrob Resist; 2019 Dec; 19():228-230. PubMed ID: 31100506 [TBL] [Abstract][Full Text] [Related]
37. A laboratory-based study to identify and speciate non-tuberculous mycobacteria isolated from specimens submitted to a central tuberculosis laboratory from throughout KwaZulu-Natal Province, South Africa. Sookan L; Coovadia YM S Afr Med J; 2014 Nov; 104(11):766-8. PubMed ID: 25909119 [TBL] [Abstract][Full Text] [Related]
38. Shipley ST; Johnson DK; Roodgar M; Smith DG; Montgomery CA; Lloyd SM; Higgins JA; Kriel EH; Klein HJ; Porter WP; Nazareno JB; Houghton PW; Panda A; DeTolla LJ Comp Med; 2017 Aug; 67(4):368-375. PubMed ID: 28830585 [TBL] [Abstract][Full Text] [Related]
39. Clinical, radiological and molecular features of Mycobacterium kansasii pulmonary disease. Bakuła Z; Kościuch J; Safianowska A; Proboszcz M; Bielecki J; van Ingen J; Krenke R; Jagielski T Respir Med; 2018 Jun; 139():91-100. PubMed ID: 29858008 [TBL] [Abstract][Full Text] [Related]
40. Mycobacterium kansasii Infection in a Patient Receiving Biologic Therapy-Not All Reactive Interferon Gamma Release Assays Are Tuberculosis. Saleem N; Saba R; Maddika S; Weinstein M Am J Med Sci; 2017 Apr; 353(4):394-397. PubMed ID: 28317629 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]